Focus Taiwan App
Download

Taiwan FDA reviewing data on Novavax vaccine following EUA request

05/14/2022 03:10 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taiwan's Food and Drug Administration (FDA) on Saturday said it was reviewing the technical data on the Novavax COVID-19 vaccine following the American drugmaker's recent request for emergency use authorization (EUA) in Taiwan.


(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.
    172.30.142.75